UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 10, 2006
SELECT MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
Delaware
(State or other jurisdiction of
Incorporation)
|
|
000-32499
(Commission File
Number)
|
|
23-2872718
(I.R.S. Employer
Identification No.) |
4716 Old Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA 17055
(Address of principal executive offices) (Zip Code)
(717) 972-1100
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
| |
|
|
o
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
o
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Item 7.01 Regulation FD Disclosure
Attached
as Exhibit 99.1 and furnished for purposes of Regulation FD is an Investor
Presentation to be given by Select Medical Corporation (the
“Company”) at the JPMorgan 24th Annual
Healthcare Conference in San Francisco, California on or about
January 10, 2006. A reconciliation of Net Income to Adjusted
EBITDA for the Company for the periods indicated is attached as
Exhibit 99.2 to this report.
The
information in this report (including Exhibit 99.1 and
Exhibit 99.2) is being furnished pursuant to Item
7.01 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange
Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall
it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the
Exchange Act.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
|
|
|
|
| |
SELECT MEDICAL CORPORATION
|
|
| Date: January 10, 2006 |
By: |
/s/ Michael E. Tarvin
|
|
| |
|
Michael E. Tarvin |
|
| |
|
Senior Vice President, General Counsel and
Secretary |
|